SCHEMBL26206182

SCHEMBL26206182

CCO[C@@H]1CCN(C(C)C)C1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 19/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20322513 1.00 HRH3 (0.38) HRH3
SCHEMBL26206179 1.00 HRH3 (0.38) HRH3
SCHEMBL22251602 0.89 HRH3 (0.33) HRH3
SCHEMBL12026463 0.89 HRH3 (0.33) HRH3
SCHEMBL2603278 0.88 HRH3 (0.43) HRH3
SCHEMBL8440295 0.83 HRH3 (0.30) HRH3
SCHEMBL22388199 0.82 HRH3 (0.37) HRH3
SCHEMBL22560621 0.82 HRH3 (0.37) HRH3
SCHEMBL19939669 0.82 HRH3 (0.42) HRH3
SCHEMBL21191798 0.81 HRH3 (0.42) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150394-A1 METHODS FOR TREATMENT OF CANCER FRONTIER MEDICINES CORPORATION (US) 2023-08-10 WO disclosed